UZH-Logo

Maintenance Infos

Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma


Guenova, E; Schanz, S; Hoetzenecker, W; DeSimone, J A; Mehra, T; Voykov, B; Urosevic-Maiwald, M; Berneburg, M; Dummer, R; French, L E; Kerl, K; Kamarashev, J; Fierlbeck, G; Cozzio, A (2014). Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma. British Journal of Dermatology, 171(4):891-894.

Abstract

BACKGROUND Primary cutaneous γ/δ T-cell lymphoma (PCGD-TCL) is aggressive and has a poor prognosis. In contrast, subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the α/β T-cell receptor phenotype is known to follow an indolent course and have a more favourable prognosis. In the past, PCGD-TCL and SPTCL were often considered to be a manifestation of the same disease, and aggressive systemic polychemotherapy has commonly been the first-line therapy for both. Given the understanding that SPTCL is a separate and less aggressive entity, clinical data exclusively evaluating the efficacy of conservative treatment in SPTCL are needed. OBJECTIVES To assess the overall clinical response to systemic corticosteroids in the treatment of SPTCL. METHODS This was a retrospective cross-sectional study based on a patient data repository from two tertiary care university hospitals in Zürich (Switzerland) and Tübingen (Germany). The repository spanned 13 years. RESULTS In four of the five patients (80%) with SPTCL, treatment with systemic corticosteroids induced a complete remission. CONCLUSIONS Systemic corticosteroids may be an excellent first-line single-agent therapy for SPTCL.

BACKGROUND Primary cutaneous γ/δ T-cell lymphoma (PCGD-TCL) is aggressive and has a poor prognosis. In contrast, subcutaneous panniculitis-like T-cell lymphoma (SPTCL) of the α/β T-cell receptor phenotype is known to follow an indolent course and have a more favourable prognosis. In the past, PCGD-TCL and SPTCL were often considered to be a manifestation of the same disease, and aggressive systemic polychemotherapy has commonly been the first-line therapy for both. Given the understanding that SPTCL is a separate and less aggressive entity, clinical data exclusively evaluating the efficacy of conservative treatment in SPTCL are needed. OBJECTIVES To assess the overall clinical response to systemic corticosteroids in the treatment of SPTCL. METHODS This was a retrospective cross-sectional study based on a patient data repository from two tertiary care university hospitals in Zürich (Switzerland) and Tübingen (Germany). The repository spanned 13 years. RESULTS In four of the five patients (80%) with SPTCL, treatment with systemic corticosteroids induced a complete remission. CONCLUSIONS Systemic corticosteroids may be an excellent first-line single-agent therapy for SPTCL.

Citations

3 citations in Web of Science®
1 citation in Scopus®
Google Scholar™

Altmetrics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
Dewey Decimal Classification:610 Medicine & health
Date:October 2014
Deposited On:13 Feb 2015 08:36
Last Modified:05 Apr 2016 19:05
Publisher:Wiley-Blackwell Publishing, Inc.
ISSN:0007-0963
Publisher DOI:https://doi.org/10.1111/bjd.13053
PubMed ID:24725144

Download

Full text not available from this repository.View at publisher

TrendTerms

TrendTerms displays relevant terms of the abstract of this publication and related documents on a map. The terms and their relations were extracted from ZORA using word statistics. Their timelines are taken from ZORA as well. The bubble size of a term is proportional to the number of documents where the term occurs. Red, orange, yellow and green colors are used for terms that occur in the current document; red indicates high interlinkedness of a term with other terms, orange, yellow and green decreasing interlinkedness. Blue is used for terms that have a relation with the terms in this document, but occur in other documents.
You can navigate and zoom the map. Mouse-hovering a term displays its timeline, clicking it yields the associated documents.

Author Collaborations